journal
Journals Neoplasia : An International J...

Neoplasia : An International Journal for Oncology Research

https://read.qxmd.com/read/38631214/modulation-of-mitochondrial-function-by-extracellular-acidosis-in-tumor-cells-and-normal-fibroblasts-role-of-signaling-pathways
#1
JOURNAL ARTICLE
Carmen Degitz, Sarah Reime, Christina-Marie Baumbach, Mandy Rauschner, Oliver Thews
In many tumors pronounced extracellular acidosis resulting from glycolytic metabolism is found. Since several environmental stress factors affect the mitochondrial activity the aim of the study was to analyze the impact of acidosis on cellular oxygen consumption and which signaling pathways may be involved in the regulation. In two tumor cell lines and normal fibroblasts cellular oxygen consumption rate (OCR) and mitochondrial function were measured after 3 h at pH 6.6. Besides the activation of ERK1/2, p38 and PI3K signaling in the cytosolic and mitochondrial compartment, the mitochondrial structure and proteins related to mitochondria fission were analyzed...
April 16, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38593698/combined-braf-and-pim1-inhibitory-therapy-for-papillary-thyroid-carcinoma-based-on-brafv600e-regulation-of-pim1-synergistic-effect-and-metabolic-mechanisms
#2
JOURNAL ARTICLE
Qianqian Xu, Jiaqi Wang, Yuting Mao, Ziyang Xuan, Ke Yang, Xi Tang, Xin Zhu
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy, and its incidence has increased rapidly in recent years. The BRAF inhibitor vemurafenib is effective against BRAFV600E-positive PTC; however, acquired resistance to single agent therapy frequently leads to tumor recurrence and metastasis, underscoring the need to develop tailored treatment strategies. We previously showed that the oncogenic kinase PIM1 was associated with the malignant phenotype and prognosis of PTC. In this study, we showed that sustained expression of the PIM1 protein in PTC was affected by the BRAFV600E mutation...
April 8, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38574506/corrigendum-to-characterizing-the-therapeutic-potential-of-a-potent-bet-degrader-in-merkel-cell-carcinoma-neoplasia-volume-21-issue-3-2019-322-330
#3
Jae Eun Choi, Monique E Verhaegen, Sahr Yazdani, Rohit Malik, Paul W Harms, Doris Mangelberger, Jean Tien, Xuhong Cao, Yuping Wang, Marcin Cieślik, Jonathan Gurkan, Mishaal Yazdani, Xiaojun Jing, Kristin Juckette, Fengyun Su, Rui Wang, Bing Zhou, Ingrid J Apel, Shaomeng Wang, Andrzej A Dlugosz, Arul M Chinnaiyan
No abstract text is available yet for this article.
April 3, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38569377/retraction-notice-to-role-of-autophagy-as-a-survival-mechanism-for-hypoxic-cells-in-tumors-neoplasia-18-2016-347-355-201
#4
JOURNAL ARTICLE
Qian Tan, Marina Wang, Man Yu, Junyan Zhang, Robert G Bristow, Richard P Hill, Ian F Tannock
No abstract text is available yet for this article.
April 2, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38537553/preliminary-insights-on-the-mutational-spectrum-of-brca1-and-brca2-genes-in-pakhtun-ethnicity-breast-cancer-patients-from-khyber-pakhtunkhwa-kp-pakistan
#5
JOURNAL ARTICLE
Hilal Ahmad, Asif Ali, Roshan Ali, Ali Talha Khalil, Ishaq Khan, Mah Muneer Khan, Mohammed Alorini
Gene mutations are a source of genetic instability which fuels the progression of cancer. Mutations in BRCA1 and BRCA2 are considered as major drivers in the progression of breast cancer and their detection indispensable for devising therapeutic and management approaches. The current study aims to identify novel pathogenic and recurrent mutations in BRCA1 and BRCA2 in Pakhtun population from the Khyber Pakhtunkhwa. To determine the BRCA1 and BRCA2 pathogenic mutation prevalence in Pakhtun population from KP, whole exome sequencing of 19 patients along with 6 normal FFPE embedded blocks were performed...
March 26, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38520790/a-synergistic-approach-for-modulating-the-tumor-microenvironment-to-enhance-nano-immunotherapy-in-sarcomas
#6
JOURNAL ARTICLE
Fotios Mpekris, Myrofora Panagi, Antonia Charalambous, Chrysovalantis Voutouri, Christina Michael, Antonia Papoui, Triantafyllos Stylianopoulos
The lack of properly perfused blood vessels within tumors can significantly hinder the distribution of drugs, leading to reduced treatment effectiveness and having a negative impact on the quality of life of patients with cancer. This problem is particularly pronounced in desmoplastic cancers, where interactions between cancer cells, stromal cells, and the fibrotic matrix lead to tumor stiffness and the compression of most blood vessels within the tumor. To address this issue, two mechanotherapy approaches-mechanotherapeutics and ultrasound sonopermeation-have been employed separately to treat vascular abnormalities in tumors and have reached clinical trials...
March 22, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38513469/disease-burden-and-projection-of-total-and-early-onset-colorectal-cancer-in-gulf-cooperation-council-countries-from-1990-to-2019
#7
JOURNAL ARTICLE
Majed Ramadan, Hanin Ghamdi, Doaa Aboalola, Noha Alorainan, Ragad Alsalmi, Ahmed Afash, Albaraa Hariri, Atheer Alboloshi, Alaa Samkari, Rawiah Alsiary
BACKGROUND: Early-onset colorectal cancer (EO-CRC) incidence and prevalence trends in the rise in high income countries, such as the Gulf Cooperation Council (GCC) countries. The study aimed to offer an up-to-date assessment of the overall burden of CRC, and EO-CRC in GCC countries and project its incidence and mortality in 2030. METHOD: The prevalence, incidence, mortality, years of life lived with disability (YLDs), and disability-adjusted life years (DALYs) of CRC were obtained from the Global Burden of Disease (GBD) Study 2019...
March 20, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38507887/dihydroartemisinin-a-potential-ptgs1-inhibitor-potentiated-cisplatin-induced-cell-death-in-non-small-cell-lung-cancer-through-activating-ros-mediated-multiple-signaling-pathways
#8
JOURNAL ARTICLE
Lianli Ni, Xinping Zhu, Qi Zhao, Yiwei Shen, Lu Tao, Ji Zhang, Han Lin, Weishan Zhuge, Young-Chang Cho, Ri Cui, Wangyu Zhu
Dihydroartemisinin (DHA) exerts an anti-tumor effect in multiple cancers, however, the molecular mechanism of DHA and whether DHA facilitates the anti-tumor efficacy of cisplatin in non-small cell lung cancer (NSCLC) are unclear. Here, we found that DHA potentiated the anti-tumor effects of cisplatin in NSCLC cells by stimulating reactive oxygen species (ROS)-mediated endoplasmic reticulum (ER) stress, C-Jun-amino-terminal kinase (JNK) and p38 MAPK signaling pathways both in vitro and in vivo. Of note, we demonstrated for the first time that DHA inhibits prostaglandin G/H synthase 1 (PTGS1) expression, resulting in enhanced ROS production...
March 19, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38492449/corrigendum-to-androgen-receptor-degraders-overcome-common-resistance-mechanisms-developed-during-prostate-cancer-treatment-neoplasia-volume-22-issue-2-2020-111-119
#9
Steven Kregel, Chao Wang, Xin Han, Lanbo Xiao, Ester Fernandez-Salas, Pushpinder Bawa, Brooke L McCollum, Kari Wilder-Romans, Ingrid J Apel, Xuhong Cao, Corey Speers, Shaomeng Wang, Arul M Chinnaiyan
No abstract text is available yet for this article.
March 15, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38489912/pik3r1-fusion-drives-chemoresistance-in-ovarian-cancer-by-activating-erk1-2-and-inducing-rod-and-ring-like-structures
#10
JOURNAL ARTICLE
Heidi Rausio, Alejandra Cervera, Vanina D Heuser, Gun West, Jaana Oikkonen, Elena Pianfetti, Marta Lovino, Elisa Ficarra, Pekka Taimen, Johanna Hynninen, Rainer Lehtonen, Sampsa Hautaniemi, Olli Carpén, Kaisa Huhtinen
Gene fusions are common in high-grade serous ovarian cancer (HGSC). Such genetic lesions may promote tumorigenesis, but the pathogenic mechanisms are currently poorly understood. Here, we investigated the role of a PIK3R1-CCDC178 fusion identified from a patient with advanced HGSC. We show that the fusion induces HGSC cell migration by regulating ERK1/2 and increases resistance to platinum treatment. Platinum resistance was associated with rod and ring-like cellular structure formation. These structures contained, in addition to the fusion protein, CIN85, a key regulator of PI3K-AKT-mTOR signaling...
March 14, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38479191/advancing-glioblastoma-treatment-by-targeting-metabolism
#11
REVIEW
Jinyi Zhao, Xuemei Ma, Peixian Gao, Xueqi Han, Pengxiang Zhao, Fei Xie, Mengyu Liu
Alterations in cellular metabolism are important hallmarks of glioblastoma(GBM). Metabolic reprogramming is a critical feature as it meets the higher nutritional demand of tumor cells, including proliferation, growth, and survival. Many genes, proteins, and metabolites associated with GBM metabolism reprogramming have been found to be aberrantly expressed, which may provide potential targets for cancer treatment. Therefore, it is becoming increasingly important to explore the role of internal and external factors in metabolic regulation in order to identify more precise therapeutic targets and diagnostic markers for GBM...
March 12, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38467087/st6gal1-is-associated-with-poor-response-to-chemoradiation-in-rectal-cancer
#12
JOURNAL ARTICLE
Mary Smithson, Sameer Al Diffalha, Regina K Irwin, Gregory Williams, M Chandler McLeod, Vivek Somasundaram, Susan L Bellis, Karin M Hardiman
INTRODUCTION: Colorectal cancer is the third most common cause of cancer death. Rectal cancer makes up a third of all colorectal cases. Treatment for locally advanced rectal cancer includes chemoradiation followed by surgery. We have previously identified ST6GAL1 as a cause of resistance to chemoradiation in vitro and hypothesized that it would be correlated with poor response in human derived models and human tissues. METHODS: Five organoid models were created from primary human rectal cancers and ST6GAL1 was knocked down via lentivirus transduction in one model...
March 10, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38422751/il-6-facilitates-cross-talk-between-epithelial-cells-and-tumor-associated-macrophages-in-helicobacter-pylori-linked-gastric-carcinogenesis
#13
JOURNAL ARTICLE
Bingting Yu, Danny de Vos, Xiaopei Guo, SanFei Peng, Wenjie Xie, Maikel P Peppelenbosch, Yang Fu, Gwenny M Fuhler
PURPOSE: Helicobacter pylori (H. pylori) is a significant risk factor for development of gastric cancer (GC), one of the deadliest malignancies in the world. However, the mechanism by which H. pylori induces gastric oncogenesis remains unclear. Here, we investigated the function of IL-6 in gastric oncogenesis and macrophage-epithelial cell interactions. METHODS: We analyzed publicly available datasets to investigate the expression of IL-6 and infiltration of M2 macrophages in GC tissues, and determine the inter-cellular communication in the context of IL-6...
February 28, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38417223/glypican-1-targeted-antibody-drug-conjugate-inhibits-the-growth-of-glypican-1-positive-glioblastoma
#14
JOURNAL ARTICLE
Shun Uchida, Satoshi Serada, Yuji Suzuki, Eiji Funajima, Kei Kitakami, Kazumasa Dobashi, Satomi Tamatani, Yuichi Sato, Takaaki Beppu, Kuniaki Ogasawara, Testuji Naka
Glioblastoma is the deadliest form of brain tumor. The presence of the blood-brain barrier (BBB) significantly hinders chemotherapy, necessitating the development of innovative treatment options for this tumor. This report presents the in vitro and in vivo efficacy of an antibody-drug conjugate (ADC) that targets glypican-1 (GPC1) in glioblastoma. The GPC1-ADC was created by conjugating a humanized anti-GPC1 antibody (clone T2) with monomethyl auristatin E (MMAE) via maleimidocaproyl-valine-citrulline-p-aminobenzyloxycarbonyl linkers...
February 27, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38417222/identification-of-recurrent-braf-non-v600-mutations-in-intraductal-carcinoma-of-the-prostate-in-chinese-populations
#15
JOURNAL ARTICLE
Jing Hu, Xinyi Chen, Feifei Sun, Lili Liu, Long Liu, Zimeng Yang, Hanwen Zhang, Zeyuan Yu, Ru Zhao, Yueyao Wang, Hui Liu, Xiaorong Yang, Fusheng Sun, Bo Han
While BRAF alterations have been established as a driver in various solid malignancies, the characterization of BRAF alterations in prostate cancer (PCa) has not been thoroughly interrogated. By bioinformatics analysis, we first found that BRAF alterations were associated with advanced PCa and exhibited mutually exclusive pattern with ERG alteration across multiple cohorts. Of the most interest, recurrent non-V600 BRAF mutations were found in 3 of 21 (14.3 %) PCa patients demonstrating IDC-P morphology. Furthermore, experimental overexpression of BRAFK601E and BRAFL597R exhibited emergence of oncogenic phenotypes with intensified MAPK signaling in vitro, which could be targeted by MEK inhibitors...
February 27, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38412576/a-deep-learning-based-holistic-diagnosis-system-for-immunohistochemistry-interpretation-and-molecular-subtyping
#16
JOURNAL ARTICLE
Lin Fan, Jiahe Liu, Baoyang Ju, Doudou Lou, Yushen Tian
BACKGROUND: Breast cancer in different molecular subtypes, which is determined by the overexpression rates of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), progesterone receptor (PR), and Ki67, exhibit distinct symptom characteristics and sensitivity to different treatment. The immunohistochemical method, one of the most common detecting tools for tumour markers, is heavily relied on artificial judgment and in clinical practice, with an inherent limitation in interpreting stability and operating efficiency...
February 26, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38401480/corrigendum-to-hedgehog-gli1-transcriptionally-regulates-fancd2-in-ovarian-tumor-cells-its-inhibition-induces-hr-deficiency-and-synergistic-lethality-with-parp-inhibition-neoplasia-volume-23-issue-9-september-2021-pages-1002-1015
#17
Chinnadurai Mani, Kaushlendra Tripathi, Sandeep Chaudhary, Ranganatha R Somasagara, Rodney P Rocconi, Chiquito Crasto, Mark Reedy, Mohammad Athar, Komaraiah Palle
No abstract text is available yet for this article.
February 23, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38387107/who-benefit-from-adjuvant-chemotherapy-in-stage-i-lung-adenocarcinoma-a-multi-dimensional-model-for-candidate-selection
#18
JOURNAL ARTICLE
Meng-Qi Jiang, Li-Qiang Qian, Yu-Jia Shen, Yuan-Yuan Fu, Wen Feng, Zheng-Ping Ding, Yu-Chen Han, Xiao-Long Fu
BACKGROUND: Despite promising overall survival of stage I lung adenocarcinoma (LUAD) patients, 10-25 % of them still went through recurrence after surgery. [1] While it is still disputable whether adjuvant chemotherapy is necessary for stage I patients. [2] IASLC grading system for non-mucinous LUAD shows that minor high-grade patterns are significant indicator of poor prognosis. [3] Other risk factors, such as, pleura invasion, lympho-vascular invasion, STAS, etc. are also related to poor prognosis...
February 21, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38382442/single-cell-analysis-unveils-the-commonality-and-heterogeneity-between-nasopharyngeal-and-oropharyngeal-carcinoma
#19
JOURNAL ARTICLE
Liping Wang, Shuang Li, Xinran Li, Guangzheng Zhuo, Qian Zhang, Guohong Liu, Yunbao Pan
Nasopharyngeal carcinoma (NPC) and oropharyngeal carcinoma (OPC) are subtypes of head and neck cancer with different treatment effects due to the heterogeneity of tumor microenvironments. This study was to investigate the distinctive tumor microenvironments of NPC and OPC. Analyzing single-cell data from 10 cases of each subtype, we reveal significant differences in cellular composition, with NPC microenvironment dominated by T/NK and B cells, and OPC characterized by prevalent epithelial cells and fibroblasts...
February 20, 2024: Neoplasia: An International Journal for Oncology Research
https://read.qxmd.com/read/38364355/targeting-myeloma-metabolism-how-abnormal-metabolism-contributes-to-multiple-myeloma-progression-and-resistance-to-proteasome-inhibitors
#20
REVIEW
Xiang Zhou, Rui He, Wei-Xin Hu, Saiqun Luo, Jingping Hu
Multiple myeloma is a hematological malignancy that has evolved from antibody-secreting B lymphocytes. Like other types of cancers, myeloma cells have acquired functional capabilities which are referred to as "Hallmarks of Cancer", and one of their most important features is the metabolic disorders. Due to the high secretory load of the MM cells, the first-line medicine proteasome inhibitors have found their pronounced effects in MM cells for blocking the degradation of misfolded proteins, leading to their accumulation in the ER and overwhelming ER stress...
February 15, 2024: Neoplasia: An International Journal for Oncology Research
journal
journal
34646
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.